Zofenopril and ramipril in patients with left ventricular systolic dysfunction after acute myocardial infarction: A propensity analysis of the Survival of Myocardial Infarction Long-term Evaluation (SMILE) 4 study
Introduction: This was a propensity score analysis of the prospective, randomized, double-blind Survival of Myocardial Infarction Long-term Evaluation (SMILE) 4 study in which one-year treatment with zofenopril 60 mg plus acetylsalicylic acid (ASA) 100 mg gave superior results compared to ramipril 1...
Main Authors: | Claudio Borghi, Stefano Omboni, Salvatore Novo, Dragos Vinereanu, Giuseppe Ambrosio, Ettore Ambrosioni |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi - SAGE Publishing
2016-09-01
|
Series: | Journal of the Renin-Angiotensin-Aldosterone System |
Online Access: | https://doi.org/10.1177/1470320316656480 |
Similar Items
-
Cost-effectiveness of zofenopril in patients with left ventricular systolic dysfunction after acute myocardial infarction: a post hoc analysis of SMILE-4
by: Borghi C, et al.
Published: (2013-07-01) -
Effects of treatment with zofenopril in men and women with acute myocardial infarction: gender analysis of the SMILE Program.
by: Flavia Franconi, et al.
Published: (2014-01-01) -
Effects of early treatment with zofenopril in patients with myocardial infarction and metabolic syndrome: the SMILE Study
by: Claudio Borghi, et al.
Published: (2008-06-01) -
Zofenopril versus ramipril in the early phase of acute myocardial infarction with systolic dysfunction: A retrospective study
by: Xiaoyang Liu, et al.
Published: (2020-09-01) -
COMPARISON BETWEEN ZOFENOPRIL AND RAMIPRIL IN COMBINATION WITH ACETYLSALICYLIC ACID IN PATIENTS WITH LEFT VENTRICULAR SYSTOLIC DYSFUNCTION AFTER ACUTE MYOCARDIAL INFARCTION: RESULTS OF A RANDOMIZED, DOUBLE-BLIND, PARALLEL-GROUP, MULTICENTER, EUROPEAN STUDY (SMILE-4)
by: C. Borghi
Published: (2012-08-01)